HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 617 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,454,005 | +81.4% | 118,225 | -1.3% | 8.68% | +62.5% |
| Q3 2022 | $7,417,000 | -22.6% | 119,836 | -0.2% | 5.34% | -15.2% |
| Q2 2022 | $9,578,000 | -25.3% | 120,090 | -1.4% | 6.30% | -7.3% |
| Q1 2022 | $12,819,000 | -0.9% | 121,840 | +1.5% | 6.80% | +6.7% |
| Q4 2021 | $12,931,000 | -0.9% | 119,995 | +0.7% | 6.37% | -3.5% |
| Q3 2021 | $13,053,000 | +16.6% | 119,161 | -0.3% | 6.60% | +15.4% |
| Q2 2021 | $11,192,000 | -48.8% | 119,526 | -49.7% | 5.72% | -9.0% |
| Q1 2021 | $21,852,000 | +118.1% | 237,422 | +73.4% | 6.28% | +8.9% |
| Q4 2020 | $10,018,000 | -17.9% | 136,954 | -12.8% | 5.77% | -36.8% |
| Q3 2020 | $12,195,000 | +30.7% | 156,994 | -6.5% | 9.13% | +14.3% |
| Q2 2020 | $9,333,000 | +73.9% | 167,928 | -7.3% | 7.99% | +24.4% |
| Q1 2020 | $5,366,000 | -19.0% | 181,168 | -1.0% | 6.42% | +9.6% |
| Q4 2019 | $6,627,000 | +41.8% | 183,054 | +6.7% | 5.86% | +28.6% |
| Q3 2019 | $4,673,000 | – | 171,621 | – | 4.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |